Trial on the Effect of Optically Modified Fiber Mattress Covers on Sleep Disturbances in Patients With Chronic Back Pain
Primary Purpose
Back Pain, Insomnia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Active Mattress Cover
Placebo Mattress Cover
Sponsored by
About this trial
This is an interventional treatment trial for Back Pain focused on measuring Back Pain, Sleep
Eligibility Criteria
Inclusion Criteria:
You are eligible to participate in this study if you:
- have a clinical diagnosis of chronic lower back pain
- have pain measured on the Visual Analogue scale
- have sleep disturbances at night associated with chronic lower back pain
- are 18 years or older
- sign the written, informed consent form prior to the initiation of any study procedures
- have an habitual bedtime between 8 P.M. and 12 A.M.
- are on a stable pain management regime
Exclusion Criteria:
You are not eligible to participate in this study if you:
- are unwilling or unable to comply with the protocol or scheduled appointments
- are unable to understand the language in which the approved informed consent is written
- have no pain measured on the Visual Analogue scale
- are unable to walk, wheel chair bound or confined to bed
- are deemed by the investigator to be unreliable to wear the actigraphy, to complete the sleep log, to use the provided mattress covers at the proper time, to come to the scheduled visits or to answer questions regarding the subject's condition or medication use
- lack a mobile arm to which to attach an actigraphy.
- are currently participate or participated in another clinical study within the past 30 days
- demonstrate an unwillingness to comply with the maximum limit of two alcoholic drinks per day and only 1 alcoholic drink after 6:00 P.M. for the duration of the protocol
- use tobacco products or any other products during nightly awakenings that may interfere with the sleep wake cycle
- have any unstable medical condition as determined by the investigator, or any other serious disease or condition that might affect life expectancy or make it difficult to successfully manage and follow the subject according to the protocol
Sites / Locations
- UC Irvine-MDA ALS and Neuromuscular Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Active Mattress Cover
Placebo Mattress Cover
Arm Description
Subjects in this arm will be given the placebo mattress cover followed active mattress cover .
Subjects in this arm will be given the active mattress cover followed by the placebo mattress cover.
Outcomes
Primary Outcome Measures
Optically Modified Polyethylene Terephthalate Fiber Mattress Cover (OMPETFMC) Improves Sleep Quality in Patients With Lower Back Pain as Measured by Clinical Global Impression (CGI).
The primary outcomes are the change in mean daily Clinical Global Impressions (pain and sleep) in placebo mattress compared to active mattress cover (assessed daily for 14 days per intervention).
The daily scores range from 1 (very much improved) to 7 (very much worse).
Secondary Outcome Measures
Sleep Variables (Nighttime Wake-time) Measured With Actigraphy in Patients With Lower Back Pain.
Secondary outcome: Nighttime wake-time after sleep onset with placebo mattress cover compared to active mattress cover.
Sleep Variables (Total Sleep) Measured With Actigraphy in Patients With Lower Back Pain.
Secondary outcome: Total sleep time with placebo mattress cover compared to active mattress cover.
Sleep Variables (Nocturnal Awakenings) Measured With Actigraphy in Patients With Lower Back Pain.
Secondary outcome: Number of nocturnal awakenings with placebo mattress cover compared to active mattress cover.
Sleep Variables (Sleep Efficiency) Measured With Actigraphy in Patients With Lower Back Pain.
Secondary outcome: Sleep efficiency in placebo mattress cover compared to active mattress cover.
Sleep Variables (Sleep Latency) Measured With Actigraphy in Patients With Lower Back Pain.
Secondary outcome: Sleep latency in placebo mattress cover compared to active mattress cover.
Full Information
NCT ID
NCT00969540
First Posted
August 31, 2009
Last Updated
December 2, 2014
Sponsor
University of California, Irvine
1. Study Identification
Unique Protocol Identification Number
NCT00969540
Brief Title
Trial on the Effect of Optically Modified Fiber Mattress Covers on Sleep Disturbances in Patients With Chronic Back Pain
Official Title
Double Blind, Placebo Controlled, Crossover Pilot Trial on the Effect of Optically Modified Polyethylene Terephthalate Fiber Mattress Covers on Sleep Disturbances in Patients With Chronic Back Pain
Study Type
Interventional
2. Study Status
Record Verification Date
December 2014
Overall Recruitment Status
Completed
Study Start Date
June 2009 (undefined)
Primary Completion Date
July 2011 (Actual)
Study Completion Date
July 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Irvine
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Sleep quantity and quality can be influenced by the type of mattress used. This study is being done to see if a mattress cover with optically active particles can help back pain and improve sleep quality.
Detailed Description
It is commonly observed that sleep in its quantity and quality is influenced by the type of mattress used at night. A recent study in patients with back pain showed that waterbeds and foam mattresses did influence back symptoms, function and sleep more positively than did a hard mattress. Pain improves with airbeds compared to regular innerspring mattresses. This study will analyze the effect of optically active particles mattress covers on sleep. The researcher is interested in learning if regular mattress or the study mattress cover (containing optically modified polyethylene terephthalate fiber mattress cover) is more useful in helping back pain and sleep quality.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Back Pain, Insomnia
Keywords
Back Pain, Sleep
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
8 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Active Mattress Cover
Arm Type
Active Comparator
Arm Description
Subjects in this arm will be given the placebo mattress cover followed active mattress cover .
Arm Title
Placebo Mattress Cover
Arm Type
Placebo Comparator
Arm Description
Subjects in this arm will be given the active mattress cover followed by the placebo mattress cover.
Intervention Type
Device
Intervention Name(s)
Active Mattress Cover
Intervention Description
Active Mattress Cover
Intervention Type
Device
Intervention Name(s)
Placebo Mattress Cover
Intervention Description
Placebo Mattress Cover
Primary Outcome Measure Information:
Title
Optically Modified Polyethylene Terephthalate Fiber Mattress Cover (OMPETFMC) Improves Sleep Quality in Patients With Lower Back Pain as Measured by Clinical Global Impression (CGI).
Description
The primary outcomes are the change in mean daily Clinical Global Impressions (pain and sleep) in placebo mattress compared to active mattress cover (assessed daily for 14 days per intervention).
The daily scores range from 1 (very much improved) to 7 (very much worse).
Time Frame
14 days
Secondary Outcome Measure Information:
Title
Sleep Variables (Nighttime Wake-time) Measured With Actigraphy in Patients With Lower Back Pain.
Description
Secondary outcome: Nighttime wake-time after sleep onset with placebo mattress cover compared to active mattress cover.
Time Frame
Assessed daily for 14 days per intervention.
Title
Sleep Variables (Total Sleep) Measured With Actigraphy in Patients With Lower Back Pain.
Description
Secondary outcome: Total sleep time with placebo mattress cover compared to active mattress cover.
Time Frame
Assessed daily for 14 days per intervention.
Title
Sleep Variables (Nocturnal Awakenings) Measured With Actigraphy in Patients With Lower Back Pain.
Description
Secondary outcome: Number of nocturnal awakenings with placebo mattress cover compared to active mattress cover.
Time Frame
Assessed daily for 14 days per intervention.
Title
Sleep Variables (Sleep Efficiency) Measured With Actigraphy in Patients With Lower Back Pain.
Description
Secondary outcome: Sleep efficiency in placebo mattress cover compared to active mattress cover.
Time Frame
Assessed daily for 14 days per intervention.
Title
Sleep Variables (Sleep Latency) Measured With Actigraphy in Patients With Lower Back Pain.
Description
Secondary outcome: Sleep latency in placebo mattress cover compared to active mattress cover.
Time Frame
Assessed daily for 14 days per intervention.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
You are eligible to participate in this study if you:
have a clinical diagnosis of chronic lower back pain
have pain measured on the Visual Analogue scale
have sleep disturbances at night associated with chronic lower back pain
are 18 years or older
sign the written, informed consent form prior to the initiation of any study procedures
have an habitual bedtime between 8 P.M. and 12 A.M.
are on a stable pain management regime
Exclusion Criteria:
You are not eligible to participate in this study if you:
are unwilling or unable to comply with the protocol or scheduled appointments
are unable to understand the language in which the approved informed consent is written
have no pain measured on the Visual Analogue scale
are unable to walk, wheel chair bound or confined to bed
are deemed by the investigator to be unreliable to wear the actigraphy, to complete the sleep log, to use the provided mattress covers at the proper time, to come to the scheduled visits or to answer questions regarding the subject's condition or medication use
lack a mobile arm to which to attach an actigraphy.
are currently participate or participated in another clinical study within the past 30 days
demonstrate an unwillingness to comply with the maximum limit of two alcoholic drinks per day and only 1 alcoholic drink after 6:00 P.M. for the duration of the protocol
use tobacco products or any other products during nightly awakenings that may interfere with the sleep wake cycle
have any unstable medical condition as determined by the investigator, or any other serious disease or condition that might affect life expectancy or make it difficult to successfully manage and follow the subject according to the protocol
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Annabel K Wang, MD
Organizational Affiliation
UC Irvine
Official's Role
Principal Investigator
Facility Information:
Facility Name
UC Irvine-MDA ALS and Neuromuscular Center
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Trial on the Effect of Optically Modified Fiber Mattress Covers on Sleep Disturbances in Patients With Chronic Back Pain
We'll reach out to this number within 24 hrs